chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Runny and stuffy nose; Runny and stuffy nose; Achiness; Fever; Chills; Fatigue; Not feeling well; This is a spontaneous report from a contactable consumer or other non hcp. This Consumer reported for a Male Patient (husband).  A male patient of an unspecified age received first dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 04Mar2021 as single dose for covid-19 immunization. No medical history and no concomitant medications were not reported. It was reported that Reporters husband and she both got the COVID-19 vaccine. we had no symptoms, no complications, no soreness, nothing. But now, it has been two weeks and her husband is having fever, he is having chills, he is having achiness, he is having fatigue, runny and stuffy nose and like she said it has been two weeks, it started two days ago. And we are just wondering if this could be a delayed reaction to the injection, to the vaccine or he may have sinuses or cold or something else, we are not sure. We just thought to start with you to find out if there have been others who have experienced these symptoms so long after taking the vaccine. It was stated she got to call her doctor because she just wanted to know if this was a usual occurrence. And if not, she need to go to the next person and call her doctor and ask my doctor because my husband is not feeling well and we are basically trying to get to the bottom of why he is not feeling well. Upon date 17Mar2021 it was reported that stating there are no problems after taking the 1st dose. Two days ago her husband was having a fever, his temperature is going up and down, has chills, fatigue, experienced stuffy and runny nose and body ache. Concerned if there is anybody who was reported getting the same side effects two weeks later after getting their 1st dose. The patient underwent lab tests and procedures which included body temperature: going up. The outcome for the evens was reported as unknown at the time of this report.   No follow up attempts are possible; information about Lot/batch number cannot be obtained.
Initial unsolicited report received from a pharmacist on 12 Oct 2016. This case is linked with 2016SA189772, 2016SA189781, 2016SA189791, 2016SA189792, 2016SA189793, 2016SA189794, 2016SA189795, 2016SA189796, 2016SA189798, 2016SA189799, 2016SA189800, 2016SA189801, 2016SA189802, 2016SA189803, 2016SA189804, 2016SA189805, 2016SA189806, 2016SA189807, 2016SA189808, 2016SA189809, 2016SA189810, 2016SA189811, 2016SA189812, 2016SA189813, 2016SA189814, 2016SA189815, 2016SA189816, 2016SA189817, 2016SA189818, 2016SA189819, 2016SA189820, 2016SA189821, 2016SA189822, 2016SA189823, 2016SA189824, 2016SA189825, 2016SA189826, 2016SA189827, 2016SA189828, 2016SA189829, 2016SA189830, 2016SA189831, 2016SA189832, 2016SA189833, 2016SA189834, 2016SA189835, 2016SA189836, 2016SA189837, 2016SA189838, 2016SA189839, 2016SA189840, 2016SA189841, 2016SA189842, 2016SA189843, 2016SA189844, 2016SA189845, 2016SA189846, 2016SA189847, 2016SA189848. (same batch number). This case involves a patient (gender and age not reported) who was vaccinated with a dose of FLUZONE Quadrivalent (batch number: UI669AA, expiry date: 30 June 2017, dose, dose in series, route and site of administration were not reported) intramuscularly on an unknown date (over the past month). Illness at the time of vaccination was reported as and pre-existing physician diagnosed allergies, birth defects, medical conditions was unknown. Concomitant medications were not reported. On an unknown date (over the past month), following the vaccination, the patient had developed sore throat, body aches, chills, slight malaise, tow grade temp (99-100) (systemic reaction). The patient required ER/doctor (staff development) visit. The patient's laboratory data was not reported. The patient did not take any treatment. The outcome of events was unknown. List of documents held by sender: none.
Vaccine Vial was opened on 6/18/2021 and was not discarded at end of day.  Same vial was used on Monday 6/21/2021. to vaccinate pt with.
Patient states he had a sore left tricep.  Patient states the injection site began to itch, get red, and develop a rash.
Fully vaccinated with two doses of Moderna. Tested positive for COVID 19 on 01/27/2022. Admitted to Hospital on 01/27/2022. Expired on 02/10/2022 while still hospitalized.
Last year had a very bad reaction to it; Initial information received on 21-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health care professional.  This case involves a patient of unknown demographics for whom last year had a very bad reaction to it after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a unknown dose of suspect  INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date, strength, formulation, route was unknown) in unknown administration site for Flu vaccination(Flu Immunisation). Information regarding batch number details has been requested.  On an unknown date the patient had a non-serious event of last year had a very bad reaction to it (adverse drug reaction) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported" Not Today, Flu Got shot last year as every year but not this year. Last year had a very bad reaction to it and will not take it this year. It is unknown if the patient had any medical history, concomitant disease or risk factor. It is unknown if there were lab data/results available."  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (Last year had a very bad reaction to it).  Outcome: Unknown.
Left side of her face is swollen; This is a spontaneous report from a contactable consumer reported for grandmother. A 78-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248) via an unspecified route of administration on 15Jan2021 at single dose for covid-19 immunization. Medical history included root canal from 04Jan2021. Concomitant medications were unknown. The patient got the vaccine on 15Jan2021 and 'this morning' the left side of her face was swollen on Jan2021. The patient was taking Benadryl as treatment. Outcome of the event was unknown.
Fainted approximately 5 minutes after vaccination. Inhaled smelling salts, awoke & coherent at all times. Sat patient in chair, rested about 10 minutes. Drank juice, ate cookie. Stated he felt ok. Ambulated on own with staff observation. Left with grandparents.
Tired; headache like behind my eyes, it was really strange, behind my eyes and it was a headache, very achy; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunisation. The patient previously took BNT162B2 on unspecified date dose 1 for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In 2021, the patient stated, "I just wanted to report, so I had really got very tired after that vaccine the second one that I had and I also had that was really strange of that I had a headache like behind my eyes, it was really strange, behind my eyes and it was a headache, very achy, yeah." The outcome of events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Swollen area ( 7 cm x 5  cm) on left anterior thigh.  This occurred within 24 hours after the injection.
ONSET OF REDNESS, SWELLING OF LEFT ARM APPROX. 12 HOURS AFTER ADMINISTRATION. BY 24 HOURS, LEFT ARM FROM SHOULDER TO BELOW ELBOW WAS RED, TENDER. EVALUATION ON 10/7/2004 AT 1700 AT A MEDICAL FACILITY BY MD. RX IV ANCEF. REQUIRED ED EVAL 10/7/2004 PM AND EVAL.AGAIN AT ACUTE INJURY AND ILLNESS ON 10/8/2004 FOR IV ABX. CHANGED TO ORAL ABX 10/8/2004 AND RE-EVALUATION EXPECTED IN 48 HOURS.
pt recv vax & stood up & became dizzy; sat down on chair & lost consciousness, eyes rolled back & arms & legs became stiff & contracted, jaw had tonic clonic affect; This lasted 1-2 mins; pt helped to the floor; pale & diaphoretic; c/o h/a
Hives/The hives mostly stayed on my chest, my breast had terrible rash too; I still have blotchiness on my legs; I had that rash all over my stomach, back, arms, groin, all over the place; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives/The hives mostly stayed on my chest, my breast had terrible rash too), RASH MACULAR (I still have blotchiness on my legs) and RASH (I had that rash all over my stomach, back, arms, groin, all over the place) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 027A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included ENALAPRIL, METFORMIN, GABAPENTIN (NEURONTIN), LEVOTHYROXINE SODIUM (LEVOXYL), GEMFIBROZIL, IBUPROFEN, ASCORBIC ACID (VITAMIN C ACID), ZINC, FISH OIL, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and CALCIUM for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives/The hives mostly stayed on my chest, my breast had terrible rash too), RASH MACULAR (I still have blotchiness on my legs) and RASH (I had that rash all over my stomach, back, arms, groin, all over the place). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form and HYDROCORTISONE ACETATE (HYDROCORTISONE [HYDROCORTISONE ACETATE]) at a dose of UNK dosage form. At the time of the report, URTICARIA (Hives/The hives mostly stayed on my chest, my breast had terrible rash too) and RASH (I had that rash all over my stomach, back, arms, groin, all over the place) had resolved and RASH MACULAR (I still have blotchiness on my legs) had not resolved.            Treatment information was not provided by reported.    This case was linked to MOD-2021-213312 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Jul-2021: Follow up received and contained No New Information.
High blood sugar; Dry eyes; Blur vision; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO179) via an unspecified route of administration in the left arm on 15Jun2021 at 10:00(at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, blood pressure high, chronic pain and legally blind. The patient did not receive any concomitant medications. The patient had unspecified known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Jun2021 at 04:00, the patient experienced blur vision and could have needed a new transplant in left eye, was waiting for follow up visit appointment soon. The patient also experienced high blood sugar, was waiting on call back from doctor and dry eyes. On 18Jun2021, the patient underwent blood glucose test and the result was blood sugar increased. Therapeutic measures were not taken as a result of adverse events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events blur vision, high blood sugar and dry eye was unknown at  the time of this report.
after immunization patient went to waiting area and sat down for the required waiting period of 15 minutes. approx 1 minute after sitting down he fainted. i instructed technician to call EMTS. I retrieved epipen but by the time i reached him he had regained consciousness. he was talking but said he felt faint and dizzy. i gave him water and he asked for an ice pack. his girlfriend who accompanied him said that he does not do well with needles or vaccinations and this has happened before. he concurred that this happens when he gets a needle. when police and emt came but  he refused transport or medical attention. i called him the next day to see how he was doing but it went to voicemail. i left a message that i was checking to see if he was okay and to call me back with any questions or concerns
Pt reported pain and significant swelling/warmth from shoulder down to elbow and pain in her back, started about two hours after vaccine was administered. Pt states symptoms are better upon notifying clinic today, but still has some swelling and tenderness.
Initial unsolicited report received from a consumer via other company (Pfizer) (manufacturer report number- 2016116108) on 07 March 2016. This case involves a female (age not reported) patient who was vaccinated with a dose of INFLUENZA VACCINE (Flu vaccine) (batch number, route and site of administration not reported) on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient had experienced allergy to flu vaccine. Laboratory data and corrective treatment were not reported. The outcome of event was not reported. List of documents held by sender: none.
I tested positive for Covid 02/15/2023 prescribed PAXLOVID after prescription ended Covid rebounded prescribed antibiotics cephalexin for 7 days. Received inhaler and cough medicine. Was told to isolate.
left arm pain, swelling to the lower left hand and arm, and skin color change (bruising)
Vaccines drawn up the day before were not thrown out as waste. Vaccine was administered unknowing of the expiration status.
Expired dose of Kinrix  inadvertently administered one day after expiration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number H9FM5, expiry date 07-MAY-2023) for prophylaxis.   On 08-MAY-2023, the patient received Kinrix. On 08-MAY-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: Expired dose of Kinrix  inadvertently administered one day after expiration). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 11-MAY-2023 The reporter stated that an expired dose of Kinrix was inadvertently administered one day after expiration which led to expired vaccine used. The reporter did not consent to follow up.
Pt experience localized redness around the site of the pneumonia shot, + low grade fever, just not feeling well, two weeks later was informed of the reaction and patient stated he never went to doctor and has recovered and feels fine today.
On 01/26/2021 I received my second dose of COVID  vaccine.  02/04/2021 I awoke at 3am and could see fine.  At 7am I awoke again and was seeing double from my left eye.  Was seen my an ophthalmologist and dx w 4th nerve palsy- Left eye.  I have no underlying medical conditions to explain this, ie no diabetes, HTN etc..  At this time 02//05/2021 I continue to have double vision , the image is sloping downward,  head movement and keeping my left eye open results in this woozy feeling of imbalance and nausea.
painful and severe swelling of the under arm and lymph nodes on the arm given the injection (booster) lasting 4 days as well as a fever of 101.8 which lasted about 48 hours in addition to body aches and chills
severe vertigo (symptoms highly c/w vertigo) accompanied by vomiting. unclear if symptoms more c/w labrinthitis or BPPV. pt does report episodic but frequently triggered. denies focal symptoms suggestive of vestibular stroke/central etiology.  symptoms improving by 5/26 when reported, but not yet resolved.
Hives all over body + itchiness from hives. Patient came to me at the pharmacy today (1/20/17) stating he has had hives since 1/15/17. He has been taking Benadryl but once the Benadryl wears off he feels itchy again. This is his first time taking the Fluzone HD he normally always gets Fluvirin without any adverse reactions.
Pt is reporting two or three instances where her leg began to shake involuntarily, with the fist instance happening during the night after she received her vaccination.
Red, hard, swollen rash on (L) deltoid. Chills, fever and tonsil swelling.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included ascorbic acid, atorvastatin calcium, ergocalciferol, ocrelizumab, regeneron (unknown ingredients) and zinc.  On 15-AUG-2021, the patient experienced suspected covid-19 infection(symptomatic) (suspected clinical vaccination failure). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from suspected covid-19 infection, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with regulatory authority: 90000200117; Sender's Comments: V0: 20211103997- COVID-19 VACCINE AD26.COV2.S-Suspected clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
Pt reported severe coughing involving blood lasting 3 days.  Pt did not seek care or use any medications to resolve symptoms.  Coughing self-resolved after 3 days with no other symptoms to report
patient developed fever yesterday 8/3 which went up to 103.6. Was told to treat fever with tylenol or motrin
Severe and acute pain in left arm. Could not left arm initially. From date of vaccination to present. Pain is lessening with Tylenol and Muscle Pain cremes. I feel the shot was administered to high up.(Shoulder not arm)
Administered MMR and client broke out in a rash 3 - 4 days after. She went to the ER and was told she had contact dermatitis.
ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/9/2023 ACUTE HYPOXEMIC RESPIRATORY FAILURE
Red itchy rash on upper right thigh and lower right torso.  Diagnosed as shingles and treated with antiviral prescription medication.
4 hours after injection, got right medial subconjunctival hemorrhage, 14 hours after injection, experienced chills, headaches x 2 days
(L) deltoid red, painful, indurated swollen tender and fever tx KEFLEX 250 mg BID x2d.
patient came to receive Pfizer 5-11 pediatric Bivalent booster, but got Pfizer 5-11 pediatric Mono-valent booster
Vaccine BUD 1/7/23, administered 1/8/23. Moderna ran analysis and determined the lot maintained activity necessary to protect against SARS-CoV-2 virus at time of administration.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 10-APR-2014 the patient was vaccinated with MMR II (lot#0685AE, expiration date: 02-APR-2014, dose and route not reported) dose 1. No adverse symptoms reported. Additional information has been requested.
positive COVID nasal swab on  2/17/2021 after 2 vaccine doses.  61-year-old woman with past medical history significant for GERD, borderline diabetes, hyperlipidemia who presents to the emergency department on 2/17/21 with several days of chills.  She denies any cough, fever.  She denies any nausea, vomiting, diarrhea, chest pain.  She denies any shortness of breath.  She is a household member who has a laboratory proven case of COVID-19.She is hemodynamically normal and her only symptom is chills.  I believe there would be low utility to either imaging or to further laboratory evaluation at this time.  The patient has been provided with a home pulse oximeter, anticipatory guidance, isolation precautions, return to the emergency department precautions.  She lives here in City and has access to a telephone and vehicle.
A week after receiving vaccine on May 22nd, patient says rash appeared at injection site for a couple hours and disappeared by noon.  On the 23rd of May, the same thing happened, rash appeared in the morning and disappeared by noon.  He also says whenever he takes a deep breath or presses on his chest, the place where he had a stent inserted over 20 years ago aches.  He is seeing his cardiologist on 6/11/21 and will mention the chest pain also
Pt received flu shot 10-19-13. Starting Sunday - pt c/o pain and redness at injection site. That Monday pt had rash/redness on cheeks and redness on chest pt afebrile, itchiness noted. FLUZONE intramuscular injec UH910AA 6-30-14 0.5cc.
There was no adverse event however the patient was given the janssen vaccine while they were only 17 years old at the time.
Immediately following vaccination on 6/11 the patient developed left arm pain which became bilateral and a headache.  These symptoms resolved with Advil.  On 6/13 he developed self-limited epigastric pain and later that evening he developed acute midline inferior sternal pain, which prompted ED evaluation.
This spontaneous report as received from a nurse refers to a patient of unknown age. On 19-JUN-2013, the patient was vaccinated with PNEUMOVAX23 (route and dose not provided) (lot number J000388, expiry date 21-FEB-2014). The nurse reported that PNEUMOVAX23 which was exposed to 25F for 14.5 hours was administered to a patient. No adverse effects reported. The outcome of PNEUMOVAX exposed to 25F for 14.5 hours and no adverse effects is unknown. Action taken with PNEUMOVAX23 was not reported. The reporter considered PNEUMOVAX exposed to 25F for 14.5 hours and no adverse effects to be not related to PNEUMOVAX23. Additional information has been requested.
Chills, vomiting,  fever,  malaise, headache, body aches
"Scratchy" throat, fever (felt very hot, didn't take temp), chills for 4 days. Joint pain, every joint in body (still having joint pain). Non-productive cough, deep, causing dry heaves. Last year had exact same symptoms, more severe starting 3 weeks after shot.